| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/CCM.0B013E3181B4275C |
| P698 | PubMed publication ID | 19770746 |
| P50 | author | Michael Bauer | Q50638837 |
| Matthias Kohl | Q56594914 | ||
| P2093 | author name string | Konrad Reinhart | |
| Jens Neumann | |||
| Ralf A Claus | |||
| Johannes Winning | |||
| Wolfgang Lösche | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | intensive care unit | Q5094647 |
| P304 | page(s) | 32-37 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Critical Care Medicine | Q5186605 |
| P1476 | title | Antiplatelet drugs and outcome in mixed admissions to an intensive care unit | |
| P478 | volume | 38 |
| Q41077113 | Acetylsalicylic acid in critically ill patients: a cross-sectional and a randomized trial. |
| Q37646857 | Alterations in platelet function during aging: clinical correlations with thromboinflammatory disease in older adults |
| Q36569978 | Antiplatelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients |
| Q37598223 | AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol |
| Q26780333 | Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome |
| Q35211647 | Aspirin therapy in patients with acute respiratory distress syndrome (ARDS) is associated with reduced intensive care unit mortality: a prospective analysis |
| Q35916354 | Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study |
| Q35388101 | Association of prehospitalization aspirin therapy and acute lung injury: results of a multicenter international observational study of at-risk patients |
| Q54662512 | Association of prior antiplatelet agents with mortality in sepsis patients. |
| Q33752498 | Benefit of low-dose aspirin and non-steroidal anti-inflammatory drugs in septic patients |
| Q33394357 | Beyond thrombosis: the versatile platelet in critical illness |
| Q47096645 | Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients? |
| Q30415074 | Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness |
| Q39020047 | Combination of aspirin with essential fatty acids is superior to aspirin alone to prevent or ameliorate sepsis or ARDS. |
| Q39114910 | Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients? |
| Q36018451 | Effect of Antiplatelet Therapy on Acute Respiratory Distress Syndrome and Mortality in Critically Ill Patients: A Meta-Analysis |
| Q30244785 | Effect of antiplatelet therapy on mortality and acute lung injury in critically ill patients: A systematic review and meta-analysis |
| Q99574694 | Effect of aspirin on deaths associated with sepsis in healthy older people (ANTISEPSIS): a randomised, double-blind, placebo-controlled primary prevention trial |
| Q45097939 | Effects of low-dose acetylsalicylic acid and atherosclerotic vascular diseases on the outcome in patients with severe sepsis or septic shock |
| Q30240053 | How do we approach thrombocytopenia in critically ill patients? |
| Q33864069 | Inflammation and thrombosis in cardiovascular disease. |
| Q38165517 | Lipid mediators in immune dysfunction after severe inflammation |
| Q34456208 | Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study |
| Q38005318 | Manifold beneficial effects of acetyl salicylic acid and nonsteroidal anti-inflammatory drugs on sepsis. |
| Q64069094 | NLRP3 inflammasome activation in platelets in response to sepsis |
| Q36663432 | Outcomes of severe sepsis and septic shock patients on chronic antiplatelet treatment: a historical cohort study |
| Q27013790 | PAMPs and DAMPs as triggers for DIC |
| Q92556952 | Platelets and Immune Responses During Thromboinflammation |
| Q34590168 | Platelets as immune mediators: Their role in host defense responses and sepsis |
| Q92405179 | Platelets in Sepsis: An Update on Experimental Models and Clinical Data |
| Q28481577 | Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade |
| Q33754815 | Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study |
| Q34545611 | Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: a population-based cohort study |
| Q29353399 | Prevention or Treatment of Ards With Aspirin: A Review of Preclinical Models and Meta-Analysis of Clinical Studies |
| Q38629029 | Quantifying the Effects of Prior Acetyl-Salicylic Acid on Sepsis-Related Deaths: An Individual Patient Data Meta-Analysis Using Propensity Matching. |
| Q37084772 | Risk factors for mortality in patients admitted to intensive care units with pneumonia |
| Q33894675 | Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study |
| Q34394336 | Synthesis and biological evaluation of novel indole-2-one and 7-aza-2-oxindole derivatives as anti-inflammatory agents |
| Q55018714 | The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis. |
| Q34277327 | The role of whole blood impedance aggregometry and its utilisation in the diagnosis and prognosis of patients with systemic inflammatory response syndrome and sepsis in acute critical illness |
| Q58698782 | Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia |
| Q64086271 | Treatment With Acetylsalicylic Acid Reverses Endotoxin Tolerance in Humans In Vivo: A Randomized Placebo-Controlled Study |
Search more.